Ropes Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $2.57M | Sell |
44,337
-8,943
| -17% | -$548K | 0.5% | 44 |
|
|
2023
Q2 | $3.41M | Buy |
53,280
+1,471
| +3% | +$98.6K | 0.57% | 45 |
|
|
2023
Q1 | $3.59M | Buy |
51,809
+823
| +2% | +$58K | 0.65% | 39 |
|
|
2022
Q4 | $3.67M | Sell |
50,986
-1,937
| -4% | -$146K | 0.66% | 36 |
|
|
2022
Q3 | $3.76M | Sell |
52,923
-13
| -0% | -$943 | 0.79% | 29 |
|
|
2022
Q2 | $4.08M | Sell |
52,936
-920
| -2% | -$70.1K | 0.84% | 28 |
|
|
2022
Q1 | $3.93M | Sell |
53,856
-2,506
| -4% | -$168K | 0.68% | 35 |
|
|
2021
Q4 | $3.51M | Sell |
56,362
-10,173
| -15% | -$597K | 0.62% | 45 |
|
|
2021
Q3 | $3.94M | Sell |
66,535
-3,397
| -5% | -$224K | 0.63% | 40 |
|
|
2021
Q2 | $4.67M | Buy |
69,932
+2,809
| +4% | +$183K | 0.74% | 36 |
|
|
2021
Q1 | $4.31M | Sell |
67,123
-5,162
| -7% | -$321K | 0.76% | 35 |
|
|
2020
Q4 | $4.48M | Buy |
72,285
+8,385
| +13% | +$516K | 0.7% | 26 |
|
|
2020
Q3 | $3.85M | Buy |
63,900
+642
| +1% | +$38.6K | 0.75% | 27 |
|
|
2020
Q2 | $3.72M | Sell |
63,258
-1,986
| -3% | -$119K | 0.76% | 27 |
|
|
2020
Q1 | $3.64M | Sell |
65,244
-2,514
| -4% | -$154K | 0.92% | 23 |
|
|
2019
Q4 | $4.35M | Buy |
67,758
+1,289
| +2% | +$73.8K | 0.94% | 24 |
|
|
2019
Q3 | $3.37M | Sell |
66,469
-2,112
| -3% | -$99.3K | 0.72% | 34 |
|
|
2019
Q2 | $3.11M | Sell |
68,581
-362
| -0.5% | -$16.9K | 0.66% | 34 |
|
|
2019
Q1 | $3.29M | Buy |
68,943
+1,085
| +2% | +$54K | 0.87% | 32 |
|
|
2018
Q4 | $3.53M | Buy |
67,858
+169
| +0.2% | +$9.08K | 1.02% | 29 |
|
|
2018
Q3 | $4.2M | Buy |
67,689
+1,553
| +2% | +$92.2K | 1.04% | 26 |
|
|
2018
Q2 | $3.66M | Buy |
66,136
+4,578
| +7% | +$247K | 0.99% | 25 |
|
|
2018
Q1 | $3.89M | Buy |
61,558
+1,400
| +2% | +$90.1K | 1.07% | 24 |
|
|
2017
Q4 | $3.69M | Sell |
60,158
-3,366
| -5% | -$211K | 0.96% | 26 |
|
|
2017
Q3 | $4.05M | Buy |
63,524
+71
| +0.1% | +$4.15K | 1.1% | 21 |
|
|
2017
Q2 | $3.54M | Buy |
63,453
+4,906
| +8% | +$267K | 1% | 24 |
|
|
2017
Q1 | $3.18M | Sell |
58,547
-11,479
| -16% | -$630K | 0.92% | 27 |
|
|
2016
Q4 | $4.09M | Buy |
70,026
+1,857
| +3% | +$102K | 1.28% | 18 |
|
|
2016
Q3 | $3.68M | Sell |
68,169
-17,015
| -20% | -$1.09M | 1.24% | 19 |
|
|
2016
Q2 | $6.26M | Buy |
85,184
+17,711
| +26% | +$1.25M | 2.19% | 9 |
|
|
2016
Q1 | $4.31M | Sell |
67,473
-272
| -0.4% | -$17.2K | 1.91% | 13 |
|
|
2015
Q4 | $4.66M | Buy |
67,745
+25,604
| +61% | +$1.69M | 2.05% | 12 |
|
|
2015
Q3 | $2.5M | Buy |
42,141
+11,203
| +36% | +$711K | 1.31% | 19 |
|
|
2015
Q2 | $2.06M | Buy |
30,938
+400
| +1% | +$26.4K | 1.12% | 23 |
|
|
2015
Q1 | $1.97M | Buy |
+30,538
| New | +$1.91M | 1.02% | 24 |
|
Other funds holding BMY
Ropes Wealth Advisors's BMY Position: Q3 2023 in Review
Ropes Wealth Advisors reduced its Bristol-Myers Squibb (BMY) stake by 17% in Q3 2023, selling an estimated $548K and leaving 44,337 shares worth $2.57M. The position accounts for 0.5% of the portfolio, ranked #44.
Ropes Wealth Advisors first reported a position in BMY in Q1 2015 and has held it in 35 quarters since. The position peaked at $6.26M in Q2 2016. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.
- Ropes Wealth Advisors held 44,337 shares of Bristol-Myers Squibb worth $2.57M as of Q3 2023.
- Ropes Wealth Advisors sold 8,943 Bristol-Myers Squibb shares in Q3 2023, an estimated $548K.
- Bristol-Myers Squibb made up 0.5% of Ropes Wealth Advisors's portfolio in Q3 2023, its #44 holding.
- Ropes Wealth Advisors first reported a position in Bristol-Myers Squibb in Q1 2015 and has held it in 35 quarters since.
- Ropes Wealth Advisors's Bristol-Myers Squibb position peaked at $6.26M in Q2 2016.
- 2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.
Based on Ropes Wealth Advisors's 13F filing for Q3 2023, filed 19 Oct 2023.